In the presence of SAH, hyponatremia can be especially dangerous to patients since low serum sodium has been linked to decreased intravascular volume and vasospasm, one of the leading causes of ...

The investigators subsequently monitored the long-term effects of dose-adjusted satavaptan treatment in the same group of patients with SIADH. Ten patients completed the 12-month open-label study ...

CSW leads to serum hyponatremia and hypovolemia as a result of SAH or other intracranial disease (Harrigan, 2001). CSW was first described in 1950, after symptoms of volume contraction and ...